Company intelligence / Profile preview

Shanghai Genext Medical Technology

Shanghai, China

Ownership: Private
Employees: ~11
Development stage: Other

Overview

Shanghai Genext Medical Technology develops organ preservation and transplantation technologies. The LifePort Kidney Transporter has been used in over 175,000 renal transplant procedures worldwide since 2003[3]. The LifePort Liver Transporter, using hypothermic machine perfusion (HMP), has demonstrated improved graft and patient survival compared to static cold storage in clinical trials[3]. The company's technologies support 320 transplant programs across 43 countries[3].

Therapeutic areas: NephrologyImmunologyGastroenterology
Modalities: DeviceIn vitro diagnosticSmall molecule
Industry: Therapeutic Medical Devices

Partnerships

Organ Recovery Systems, Inc.[3]

Beyond the preview

Go deeper on Shanghai Genext Medical Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shanghai Genext Medical Technology.

Explore the full profile